Sector portfolio · Growth fund · Singapore
Goldbell Group's Biotech portfolio
Goldbell Group has backed 11 Biotech startups in rounds we track, $2.0B between them, shown by the stage each has reached. The best-funded is Gossamer Bio.
Funding by segment
- Series C and later$693M6
- Series B$692M3
- Stage not reported$627M2
Where they are based
- United States10$1.9B
- Austria1$76M
United States
AustriaFounded
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M1
- $50M to $250M8
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States10
- Austria1
Startups by country, 2 countries in all.
Segment by segment
Series C and later
6 startups · $693M raised
MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M- SBSQZ BiotechnologiesUnited States$137M
VisterraVisterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.United States$120M
NeuroneticsNeuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.United States$110M
Faraday PharmaceuticalsFaraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.United States$78M
ArsanisArsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.Austria$76M
Series B
3 startups · $692M raised
Gossamer BioGossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.United States$567M
KallyopeKallyope uses the science of gut-brain biology to create medicines that transform human health.United States$95M
Lyra TherapeuticsLyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.United States$30M
Stage not reported
2 startups · $627M raised
FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
Frequency TherapeuticsFrequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.United States$74M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Goldbell Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Goldbell Group?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.